AstraZeneca PLC
Broker Recommendation (11 Brokers)GlossaryGo to Portfolio
STRONG SELL
STRONG BUY
HOLDSTRONG BUY| 2010 | 2011 | |||||
|---|---|---|---|---|---|---|
| Pre-tax (£) | EPS (p) | DPS (p) | Pre-tax (£) | EPS (p) | DPS (p) | |
| Consensus | 7,359.94 | 366.00 | 146.27 | 7,368.97 | 369.10 | 151.62 |
| 1 Month Change | -428.70 | -5.79 | -2.23 | -194.29 | 14.03 | 8.65 |
| 3 Month Change | 329.91 | 12.64 | -0.16 | -1.91 | 27.87 | 6.80 |
| 2009 (A) | 2010 (E) | 2011 (E) | ||
|---|---|---|---|---|
| Norm. EPS | % | 5.57 | -2.25 | 0.85 |
| DPS | % | 47.44 | 3.88 | 3.66 |
| 2009 (A) | 2010 (E) | 2011 (E) | ||
|---|---|---|---|---|
| EBITDA | £m | 8,520.34 | 8,815.77 | |
| EBIT | £m | 7,887.66 | 7,759.04 | |
| Dividend Yield | % | 5.06% | 5.26% | 5.45% |
| Dividend Cover | x | 2.66 | 2.50 | 2.43 |
| PER | x | 7.42 | 7.60 | 7.53 |
| PEG | f | 1.33 | -3.38 | 8.89 |
| Net Asset Value PS | p | 1,087.54 | 1,262.22 | |
Brokers
The consensus above is compiled from contributions by the following brokers:
Panmure Gordon, Exane BNP Paribas, SG Securities, WestLB, Charles Stanley, Shore Capital, Collins Stewart, Edison Investment Research, Evolution Securities Ltd, NCB Stockbrokers Ltd, ABN AMRO, Nomura Research Institute
Panmure Gordon, Exane BNP Paribas, SG Securities, WestLB, Charles Stanley, Shore Capital, Collins Stewart, Edison Investment Research, Evolution Securities Ltd, NCB Stockbrokers Ltd, ABN AMRO, Nomura Research Institute